The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD)
Recruiting
Observational Study
Head and Neck Neoplasms
Hearing Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University of Manchester · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Radiotherapy and combined radiotherapy and chemotherapy are used to treat most tumours in the head and neck region. Unfortunately, these treatments often result in hearing loss and tinnitus that has a negative impact on quality of life. This study will use a battery of sensitive tests, including measures of hair cell and neural function, before and after treatment, to measure the effects of these …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
For Prospective Patient Cohorts:
Inclusion Criteria:
* Diagnosed with head and neck cancer
* An MDT treatment decision of radiotherapy +/- cisplatin based chemotherapy
Exclusion Criteria:
* Hearing loss greater than 25 dB HL (average from 0.25 to 4 kHz) prior to the study
* Existing hearing loss…
Contacts